Metagenomi, Inc. Common Stock (MGX) Earnings Analysis

Metagenomi, Inc. Common Stock (MGX) next reports earnings on 2026-08-11, consensus EPS -0.55307 USD. Last quarter (2026-05-11) it missed with EPS -0.61 USD vs -0.6 USD est (-1.7%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -0.54.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MGX next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-0.55307 USD
Revenue estimate0.00B

MGX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.61 USD-0.6 USD-1.7%Miss
2026-03-05-0.6 USD-0.58 USD-3.4%Miss
2025-03-17-0.63 USD-0.62 USD-1.6%Miss
2024-08-14-0.29 USD-0.59 USD+50.8%Beat

Beat rate: 1/4 (25%) over reported quarters with consensus data.

MGX valuation and analyst view

Trailing P/E-0.54
Trailing EPS-2.2854 USD
Price / book0.34
Dividend yield0.00%
Market cap0.05B
Analyst consensusBuy (4 buy / 1 hold / 0 sell)

Related research pages

Frequently asked questions

When is Metagenomi, Inc. Common Stock (MGX)'s next earnings date?

Metagenomi, Inc. Common Stock is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.55307 USD and revenue estimate of 0.00B.

Did MGX beat earnings last quarter?

In its 2026-05-11 report, MGX posted EPS of -0.61 USD versus a -0.6 USD estimate — a miss of 1.7%.

What is MGX's earnings track record?

Over the last 4 reported quarters with consensus data, MGX beat estimates 1 times (25%).

What is MGX's current P/E ratio and EPS?

MGX trades at a trailing P/E of -0.54 on trailing EPS of -2.2854044642766387 USD.

What do analysts rate MGX?

Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell).